Brooke Sutherland, Columnist

A Prescription for Team Health

The physician outsourcing company is a cheaper target since it rejected advances by a rival.

February 25, 2016 at 7:31 PM UTC

Brooke Sutherland is Bloomberg News' Boston bureau chief and writes the Industrial Strength Newsletter. She was previously a Bloomberg Opinion columnist covering deals and industrial companies and an M&A reporter for Bloomberg News.

Provide news feedback or report an error

Site feedback:

Take our Survey

This article is for subscribers only.

Paging Dr. AmSurg to treat Team Health.

Activist investor Jana Partners disclosed an 8 percent stake in Team Health on Thursday and said it would seek board seats in light of "missteps" made by the $3.3 billion provider of physician outsourcing services for hospitals. One of those missteps is presumably Team Health's decision to reject takeover advances from surgical-center operator AmSurg last year. AmSurg's latest proposal valued Team Health at $69.32 a share. The compares with just $38 before news of Jana's proxy fight. 1456425218556